AMADEUS TRIAL: TUMOR AGNOSTIC PRE- AND ONTREATMENT BIOMARKERS OF RESPONSE TO NIVOLUMAB PLUS IPILIMUMAB CORRELATE WITH ONTREATMENT TUMORAL T CELL INFILTRATION

被引：1

作者：

Alayli, Farah ^{[1
]}

Okrah, Kwame ^{[1
]}

Tsimberidou, Apostolia ^{[2
]}

Drakaki, Alexandra ^{[3
]}

Khalil, Danny ^{[4
]}

Khan, Saad ^{[5
]}

Hodi, Stephen ^{[6
]}

Oh, David ^{[7
]}

Amouzgar, Meelad ^{[1
]}

Guatam, Shikha ^{[1
]}

Kageyama, Robin ^{[1
]}

Pfeiffer, Shannon ^{[1
]}

Meier, Stefanie ^{[1
]}

Cabanski, Christopher ^{[1
]}

Da Silva, Diane ^{[1
]}

Kumar, Dinesh ^{[1
]}

Santulli-Marotto, Sandra ^{[1
]}

Tetzlaff, Michael ^{[7
]}

Foo, Wai Chin ^{[2
]}

Hollman, Travis ^{[4
]}

Li, Yanyun ^{[4
]}

Adamow, Mathew ^{[4
]}

Wong, Philip ^{[4
]}

Spasic, Marko ^{[1
]}

Chen, Richard ^{[8
]}

Bucktrout, Samantha ^{[1
]}

Fairchild, Justin ^{[1
]}

Butterfield, Lisa ^{[1
]}

LaVallee, Theresa ^{[1
]}

Padron, Lacey ^{[1
]}

Salvador, Lisa ^{[9
]}

O'Donnell-Tormey, Jill ^{[10
]}

Dugan, Ute ^{[1
]}

Sharma, Padmanee ^{[2
]}

机构：

[1] Parker Inst Canc Immunotherapy, San Francisco, CA USA

[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[3] Univ Calif Los Angeles, Los Angeles, CA USA

[4] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[5] Stanford Univ, Stanford, CA 94305 USA

[6] Dana Farber Canc Inst, Boston, MA 02115 USA

[7] Univ Calif San Francisco, San Francisco, CA 94143 USA

[8] Personalis Inc, Menlo Pk, CA USA

[9] Bristol Myers Squibb, Princeton, NJ USA

[10] Canc Res Inst, New York, NY USA

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷

关键词：

D O I：

10.1136/jitc-2022-SITC2022.0587

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

587

引用

页码：A614 / A614

页数：1